Stay updated on Pembrolizumab in Advanced Penile Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Penile Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Penile Cancer Clinical Trial page
- Check6 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, indicating a minor refresh of the entry that does not modify study data, eligibility criteria, or results.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5, indicating a newer revision. This is a metadata update rather than a substantive change to the study details.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision label updated to v3.6.4, replacing the previous v3.6.3. This indicates a minor maintenance update to the page’s versioning.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3, indicating a new patch/version was applied to the page.SummaryDifference0.1%

- Check70 days agoChange DetectedThe page now shows the revision label as v3.6.2, replacing v3.6.0. This appears to be a minor site update and does not affect the study details or other content on the page.SummaryDifference0.1%

- Check84 days agoChange DetectedThe page now shows recruitment is closed with 'No longer looking for participants' and adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study). The Interventions heading formatting changes to 'Intervention / Treatment', and the revision tag updates to v3.6.0 (from v3.5.5).SummaryDifference0.6%

Stay in the know with updates to Pembrolizumab in Advanced Penile Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Penile Cancer Clinical Trial page.